drugset / Trial / NCT06667882

Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests

NCT06667882

Completed 33 enrolled Semmelweis University
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this work was to reduce the bleeding risk during thrombolysis using the viscoelastic blood coagulation tests.

Timeline

Start
2021-12-17
Primary completion
2024-10-24
Completion
2024-10-24

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic 0.04 mg/kg
Subject Alteplase Protein / enzyme biologic 0.15 mg/kg
Subject Alteplase Protein / enzyme biologic 0.6 mg/kg
Subject Alteplase Protein / enzyme biologic 100 mg